Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7131-7145

  Turnbull, Emma L ^a   Wong, MaiLee ^a   Wang, Shuyi ^b   Wei, Xiping ^b   Jones, Nicola A ^a   Conrod, Karen E ^a   Aldam, Diana ^c   Turner, Jo ^c   Pellegrino, Pierre ^c   Keele, Brandon F ^b   Williams, Ian ^c   Shaw, George M ^b   Borrow, Persephone ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL KINETICS; CELLULAR IMMUNITY; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS LOAD; CELL PROLIFERATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION;

CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; EPITOPES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; KINETICS; LYMPHOCYTE ACTIVATION; T-CELL ANTIGEN RECEPTOR SPECIFICITY; VIRAL LOAD;

EID: 67449119122     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803658     Document Type: Article

References (70)

1. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68: 4650-4655.
2. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68: 6103-6110.
3. Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L. Letvin. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162: 5127-5133. (Pubitemid 29307114)
4. + lymphocytes. Science 283: 857-860.
5. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189: 991-998.
6. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170.
7. Johnson, R. P., R. L. Glickman, J. Q. Yang, A. Kaur, J. T. Dion, M. J. Mulligan, and R. C. Desrosiers. 1997. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71: 7711-7718.
8. + T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 176: 319-328.
9. + T lymphocytes following challenge of vaccinated macaques. Virology 333: 226-238.
10. Veazey, R. S., J. D. Lifson, J. E. Schmitz, M. J. Kuroda, M. Piatak, Jr., I. Pandrea, J. Purcell, R. Bohm, J. Blanchard, K. C. Williams, and A. A. Lackner. 2003. Dynamics of simian immunodeficiency virus-specific cytotoxic T-cell responses in tissues. J. Med. Primatol. 32: 194-200.
11. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67: 1707-1711.
12. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370: 463-467.
13. Goulder, P. J., M. A. Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L. Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N. Phillips, et al. 2001. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193: 181-194.
14. + T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188: 785-790.
15. + T cells in primary HIV-1 infection. J. Virol. 77: 6867-6878.
16. Addo, M. M., X. G. Yu, A. Rathod, D. I. Cohen, R. L. Eldridge, D. Strick, M. N. Johnstone, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77: 2081-2092.
17. + cytotoxic T lymphocyte response. J. Exp. Med. 200: 1243-1256.
18. Sun, Y., E. Iglesias, A. Samri, G. Kamkamidze, T. Decoville, G. Carcelain, and B. Autran. 2003. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272: 23-34.
19. Goepfert, P. A., A. Bansal, B. H. Edwards, G. D. Ritter, Jr., I. Tellez, S. A. McPherson, S. Sabbaj, and M. J. Mulligan. 2000. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce γ interferon. J. Virol. 74: 10249-10255.
20. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
21. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
22. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
23. Altfeld, M., M. M. Addo, R. Shankarappa, P. K. Lee, T. M. Allen, X. G. Yu, A. Rathod, J. Harlow, K. O'Sullivan, M. N. Johnston, et al. 2003. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J. Virol. 77: 7330-7340.
24. Frahm, N., D. E. Kaufmann, K. Yusim, M. Muldoon, C. Kesmir, C. H. Linde, W. Fischer, T. M. Allen, B. Li, B. H. McMahon, et al. 2007. Increased sequence diversity coverage improves detection of HIV-specific T cell responses. J. Immunol. 179: 6638-6650.
25. Meyaard, L., S. A. Otto, I. P. Keet, M. T. Roos, and F. Miedema. 1994. Programmed death of T cells in human immunodeficiency virus infection: no correlation with progression to disease. J. Clin. Invest. 93: 982-988. (Pubitemid 24087147)
26. Appay, V., L. Papagno, C. A. Spina, P. Hansasuta, A. King, L. Jones, G. S. Ogg, S. Little, A. J. McMichael, D. D. Richman, and S. Rowland-Jones. 2002. Dynamics of T cell responses in HIV infection. J. Immunol. 168: 3660-3666. (Pubitemid 34250438)
27. Norris, P. J., B. L. Pappalardo, B. Custer, G. Spotts, F. M. Hecht, and M. P. Busch. 2006. Elevations in IL-10, TNF-α, and IFN-γ from the earliest point of HIV type 1 infection. AIDS Res. Hum. Retroviruses 22: 757-762.
28. Stacey, A. R., P. J. Norris, L. Qin, E. A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. Decamp, D. Li, D. Grove, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83: 3719-3733.
29. Clark, S. J., M. S. Saag, W. D. Decker, S. Campbell-Hill, J. L. Roberson, P. J. Veldkamp, J. C. Kappes, B. H. Hahn, and G. M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324: 954-960.
30. Ehl, S., P. Klenerman, P. Aichele, H. Hengartner, and R. M. Zinkernagel. 1997. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27: 3404-3413.
31. + T cells and the control of human immunodeficiency virus infection. J. Virol. 78: 10096-10103.
32. + T-cell expansion but improved virus control. J. Virol. 79: 10059-10062.
33. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. D. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
34. + T cell responses. J. Immunol. 166: 4627-4633.
35. Fuller, M., and A. Zajac. 2003. Ablation of CD8 and CD4 T cell response by high viral loads. J. Immunol. 170: 477-486. (Pubitemid 36026174)
36. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
37. + T cell response during acute and persistent murine γ-herpesvirus infection. Eur. J. Immunol. 29: 1059-1067.
38. + T-cell response to readily eliminated and persistent viruses. Philos. Trans. R. Soc. London B Biol. Sci. 355: 1093-1101.
39. + T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol. 16: 3-16.
40. Vezys, V., D. Masopust, C. C. Kemball, D. L. Barber, L. A. O'Mara, C. P. Larsen, T. C. Pearson, R. Ahmed, and A. E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203: 2263-2269.
41. Timm, J., G. M. Lauer, D. G. Kavanagh, I. Sheridan, A. Y. Kim, M. Lucas, T. Pillay, K. Ouchi, L. L. Reyor, J. Schulze zur Wiesch, et al. 2004. CD8 epitope escape and reversion in acute HCV infection. J. Exp. Med. 200: 1593-1604.
42. Day, C. L., A. K. Shea, M. A. Altfeld, D. P. Olson, S. P. Buchbinder, F. M. Hecht, E. S. Rosenberg, B. D. Walker, and S. A. Kalams. 2001. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles. J. Virol. 75: 6279-6291.
43. + T-cell responses following acute HIV-1 infection. J. Virol. 76: 8690-8701.
44. Altfeld, M., E. S. Rosenberg, R. Shankarappa, J. S. Mukherjee, F. M. Hecht, R. L. Eldridge, M. M. Addo, S. H. Poon, M. N. Phillips, G. K. Robbins, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193: 169-180.
45. Lichterfeld, M., X. G. Yu, D. Cohen, M. M. Addo, J. Malenfant, B. Perkins, E. Pae, M. N. Johnston, D. Strick, T. M. Allen, et al. 2004. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 18: 1383-1392.
46. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171: 5415-5422.
47. + T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. USA 103: 994-999.
48. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158: 1507-1515. (Pubitemid 127469502)
49. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176: 4094-4101. (Pubitemid 44264388)
50. + T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics. Trends Immunol. 26: 166-171.
51. Von Herrath, M. G., J. Dockter, M. Nerenberg, J. E. Gairin, and M. B. Oldstone. 1994. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180: 1901-1910.
52. Van der Most, R. G., L. E. Harrington, V. Giuggio, P. L. Mahar, and R. Ahmed. 2002. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology 296: 117-124.
53. + T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J. Immunol. 160: 2923-2931.
54. + T-cell responses is dramatically modified by DNA immunization and is regulated by γ interferon. J. Virol. 76: 4251-4259.
55. + (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98: 3016-3021.
56. + dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS Res. Hum. Retroviruses 16: 683-692.
57. + T cell responses with efficient natural control of primary HIV-1 infection. AIDS 18: 749-755.
58. Musey, L. K., J. N. Krieger, J. P. Hughes, T. W. Schacker, L. Corey, and M. J. McElrath. 1999. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 180: 278-284.
59. + T lymphocytes. Proc. Natl. Acad. Sci. USA 97: 3382-3387.
60. Sandberg, J. K., P. Grufman, E. Z. Wolpert, L. Franksson, B. J. Chambers, and K. Karre. 1998. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160: 3163-3169.
61. Kedl, R. M., W. A. Rees, D. A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, and P. Marrack. 2000. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192: 1105-1113.
62. + T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 94: 9848-9853.
63. + T cells after early HIV-1 infection. J. Virol. 81: 4199-4214.
64. + T cells. PLoS Med. 5: e100.
65. Price, D. A., S. M. West, M. R. Betts, L. E. Ruff, J. M. Brenchley, D. R. Ambrozak, Y. Edghill-Smith, M. J. Kuroda, D. Bogdan, K. Kunstman, et al. 2004. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21: 793-803.
66. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-611.
67. + T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 165: 1082-1092.
68. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
69. Frahm, N., B. T. Korber, C. M. Adams, J. J. Szinger, R. Draenert, M. M. Addo, M. E. Feeney, K. Yusim, K. Sango, N. V. Brown, et al. 2004. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 78: 2187-2200.
70. + T cells: correlation with viral load. J. Virol. 78: 3233-3243.